The University of Maryland School of Pharmacy in Baltimore will launch a reimagined Doctor of Pharmacy curriculum, known as M-Pact, beginning in fall 2026.
The M-Pact curriculum was developed through a multiyear review involving faculty, staff and students, according to a Feb. 16 news release from the university. It incorporates evolving best practices, updated accreditation standards and new competency frameworks from the American Association of Colleges of Pharmacy. Current students will continue under the existing PharmD program.
The revised curriculum includes six semesters of coursework focused on medication expertise, professionalism, applied science and therapeutics. Students will complete experiential learning in their final year.
University officials said M-Pact emphasizes career exploration, critical thinking, health equity and what it calls a “pharmapreneurial” mindset. Faculty will teach both the legacy and new curricula during the transition.
Approximately 8% to 10% of UMSOP graduates pursue dual degrees, the release said. The new curriculum will continue to support those opportunities across disciplines such as law, public health and regulatory science.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
